NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers
NOS1AP 和 Capon 与糖尿病足溃疡患者的愈合受损相关
基本信息
- 批准号:9925084
- 负责人:
- 金额:$ 60.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAmputationAnatomyAnimalsBiochemicalBiological ProcessBloodBone MarrowCell physiologyCellsCharacteristicsChronicClinicalCodeComplications of Diabetes MellitusDataDiabetes MellitusDiabetic Foot UlcerDiseaseEndothelial Growth Factors ReceptorEndotheliumEngineeringEnrollmentEpidemicEthnic OriginFamilyFoot UlcerGenderGenesGenetic VariationGeographic LocationsGoalsHypoxia Inducible FactorImpaired healingImpaired wound healingImpairmentIncidenceIndividualInfectionInflammasomeInflammatoryInterleukin-1 betaInterleukin-18KnowledgeLeukocytesLinkLower ExtremityMedicareNeuropathyNeutrophil ActivationNitric Oxide SynthasePathway interactionsPatientsPeripheral Vascular DiseasesPhosphorylationPlatelet ActivationPopulationPopulations at RiskProcessProductionProtein Kinase CProtein Tyrosine KinaseProteinsRaceReceptor ActivationRecording of previous eventsResearchRiskRisk FactorsSingle Nucleotide PolymorphismSurveysTXN geneTimeTraumaVariantVascular Endothelial Growth Factorsbeneficiarybiobankcare costschronic wounddiabeticfootgain of functiongenetic varianthealinghealth managementhigh riskimmunoregulationmarenostrinmortality riskprecursor cellreceptorstatisticsstemstem cellstissue repairwoundwound carewound healing
项目摘要
Project Summary/Abstract
Diabetes mellitus has reached epidemic proportions. A significant complication of diabetes is impaired
healing which results in diabetic foot ulcer (DFU) and lower extremity amputation (LEA). About 20% of those
with diabetes will develop a DFU. The annual incidence of LEA in Medicare beneficiaries with diabetes is about
4 per thousand, but rates of LEA can vary up to two- to threefold by race/ethnicity, geographic location, and
gender. Individuals with diabetes develop DFU and LEA for many reasons that probably include interactions or
alterations in intrinsic pathways responsible for wound repair, the presence of infection, changes to immune
regulation, neuropathy, peripheral vascular disease, changes in anatomic function of the foot, and local
trauma. DFUs are chronic wounds, which are by definition are wounds that have failed to follow an orderly and
timely sequence resulting in healing and have impaired healing. Those that develop chronic wounds that result
in LEA have wounds that heal slowly or not at all. Why a wound becomes chronic is not well understood.
In the past 5 years, we have developed preliminary evidence showing that genetic variation in NOS1AP,
which codes for a protein called capon, is associated with impaired healing of DFU, an increased risk of LEA,
and decrease in the number or circulating endothelial precursors cells, which have been shown to be
associated with individuals with a DFU that are less likely to heal. Our project focuses on producing further
evidence to confirm the association of NOS1AP variation with impaired healing and to discern the functional
basis of NOS1AP genetic variation on capon and ultimately capon’s influence on wound repair. To that end,
the goal of our present study is to explore the possibility that common genetic variants of NOS1AP in those
who have diabetes are associated with alterations in wound repair.
项目概要/摘要
糖尿病已达到流行的程度,糖尿病的一个重要并发症是受损。
其中约 20% 会导致糖尿病足溃疡 (DFU) 和下肢截肢 (LEA)。
患有糖尿病的人将发展为 DFU 患有糖尿病的 Medicare 受益人中 LEA 的年发病率约为
千分之 4,但 LEA 的比率可能会因种族/民族、地理位置和文化而变化高达两到三倍。
糖尿病患者出现 DFU 和 LEA 的原因有很多,其中可能包括相互作用或其他原因。
负责伤口修复的内在途径的改变、感染的存在、免疫的变化
调节、神经病变、周围血管疾病、足部解剖功能的变化以及局部
DFU 是慢性伤口,顾名思义,就是未能遵循有序、有序的伤口。
及时的顺序导致愈合并导致愈合受损。
在 LEA 中,伤口愈合缓慢或根本不愈合,但为什么伤口会变成慢性尚不清楚。
在过去的5年里,我们已经开发出初步证据表明NOS1AP的遗传变异,
它编码一种称为阉鸡的蛋白质,与 DFU 愈合受损、LEA 风险增加有关,
以及循环内皮前体细胞数量的减少,这已被证明是
与不太可能治愈的 DFU 患者相关,我们的项目重点是进一步生产。
证实 NOS1AP 变异与愈合受损之间的关联并辨别功能性的证据
阉鸡的 NOS1AP 遗传变异以及最终阉鸡对伤口修复的影响的基础。
我们目前研究的目的是探讨 NOS1AP 的常见遗传变异在这些人中的可能性
患有糖尿病的人与伤口修复的改变有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Margolis其他文献
David Margolis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Margolis', 18)}}的其他基金
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10296086 - 财政年份:2021
- 资助金额:
$ 60.51万 - 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10470869 - 财政年份:2021
- 资助金额:
$ 60.51万 - 项目类别:
Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women
螺内酯与口服四环素类抗生素治疗女性中度至重度痤疮的疗效比较
- 批准号:
9815052 - 财政年份:2019
- 资助金额:
$ 60.51万 - 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
- 批准号:
9228322 - 财政年份:2016
- 资助金额:
$ 60.51万 - 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
- 批准号:
9868281 - 财政年份:2016
- 资助金额:
$ 60.51万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8538377 - 财政年份:2012
- 资助金额:
$ 60.51万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8370929 - 财政年份:2012
- 资助金额:
$ 60.51万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8731122 - 财政年份:2012
- 资助金额:
$ 60.51万 - 项目类别:
相似国自然基金
PGE2通过EP受体调控CCL2/CCR2信号通路轴介导截肢后爆发痛的外周机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
躯体感觉皮层神经元-小胶质细胞交互作用调控截肢后继发性疼痛的神经机制
- 批准号:82171218
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
下肢截肢后外周血管阻抗改变影响心血管系统的血流动力学研究
- 批准号:
- 批准年份:2019
- 资助金额:63 万元
- 项目类别:面上项目
面向膝上截肢者融合智能下肢假肢的新型外骨骼机器人关键技术研究
- 批准号:61803272
- 批准年份:2018
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
利用靶向神经移植术重建缺失肢体运动神经信息源及机制研究
- 批准号:81760416
- 批准年份:2017
- 资助金额:34.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Applying induced pluripotent stem cell derived endothelial cells to regenerative therapy in chronic limb threatening ischemia
将诱导多能干细胞衍生的内皮细胞应用于慢性肢体威胁性缺血的再生治疗
- 批准号:
10701387 - 财政年份:2023
- 资助金额:
$ 60.51万 - 项目类别:
Novel Imaging Probe for Early Detection of Charcot Foot
用于早期检测夏科足的新型成像探头
- 批准号:
10593866 - 财政年份:2023
- 资助金额:
$ 60.51万 - 项目类别:
The Neural Circuitry of Tooth Sensation: Contribution of Additional Sensory Modalities and Plasticity Following Tooth Loss
牙齿感觉的神经回路:牙齿缺失后附加感觉方式和可塑性的贡献
- 批准号:
9516097 - 财政年份:2018
- 资助金额:
$ 60.51万 - 项目类别: